Products

MediaMarkup

Share, review, markup and approve PDF, image and video files online.

mediamarkup.com Business Operations / Document Generation & Approvals

AI Benchmark
Desktop
Mobile
Monthly visits
None yet
No traffic data yet
MRR
$1,300Claimed
Disclosed 2026-09-29Indie Hackers
Entry price
Unknown
No monthly subscription pricing
Creators
Mark Redman
@mediamarkup· 50 followers
Launched
7y ago
2019-02-03 · Est.

Traffic & revenue

Monthly visits

No traffic data yet.

MRRSelf-reported, unverified · Indie Hackers
  • Sep 2026$1,300Self-reported MRR · unverified
Events1 revenue disclosure

Revenue evidence

Publicly disclosed & verified revenue figures, sorted by date

Marketing moves

Launches, search & content, referrals, promotions
X accounts@mediamarkup

  • Launched on BetaListLaunch

    MediaMarkup – Review & Approve PDF and video content online — Review & Approve PDF and video content online

    Feb 3, 2019 · 7y agoLaunch page

Traffic sources

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

View similar products ↓

Search

Domain authority —Domain registered 2017-09-05

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-08-11

Key pages

Weekly snapshots
Home
mediamarkup.com/ Snapshot 2026-11-09

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

What is MediaMarkup and what platforms does it support?
MediaMarkup is catalogued under Document Generation & Approvals: Share, review, markup and approve PDF, image and video files online.. Supported platforms: API.
What is MediaMarkup's publicly disclosed revenue?
Indie Hackers records a founder-reported figure of $1,300 /mo stated on 2026-09-29.Source

Related products in this category

Business Operations / Document Generation & Approvals

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.